Toronto Stocks Flat; Brookfield Renewable Partners Down on $650 Million Fundraiser
By Adriano Marchese
Toronto-listed stocks were virtually flat Tuesday mid-trading, with a mixed performance from Canada's sectors. Gains were primarily in health tech stocks, followed by energy and communications. The biggest laggards were in tech, materials and utilities stocks.
At midday, Canada's S&P/TSX Composite Index remained unchanged at 30316.57 and the blue-chip S&P/TSX 60 rose slightly, by 0.1% to 1787.02.
Shares of Brookfield Renewable Partners fell by 6% to 41.03 Canadian dollars ($29.26) after the company said that it will raise $650 million to fund recent acquisitions and for future investment opportunities.
Other market movers:
Calian Group shares rose by 7.2% to C$52.12 after the company's management agreed to change up its board and form a new committee to oversee the divestment of noncore businesses following pressure from one of its largest shareholders, Plantro.
Profound Medical shares rose by 11% to C$9.25 after regaining distribution rights for its medical device system, Tulsa-Pro, used to destroy prostate cancer tissue previous licensed out.
Kits Eyecare's shares rose by 9% to C$13.63 after the eyecare provider kicked off November with what it said were a week of record-breaking sales.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
November 11, 2025 12:28 ET (17:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States